Cargando…

Immune response in cutaneous leishmaniasis patients with healing vs. non-healing lesions

BACKGROUND AND OBJECTIVES: The outcome of Leishmania infection mainly depends upon the Leishmania species which causes the disease and the generation of the type of host immune response, the healing process and protection in leishmaniasis depends upon induction of Th1 response. In this study, the Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miramin-Mohammadi, Akram, Javadi, Amir, Eskandari, Seyed Ebrahim, Mortazavi, Hossein, Rostami, Mahmoud Nateghi, Khamesipour, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340611/ https://www.ncbi.nlm.nih.gov/pubmed/32685122

Ejemplares similares

Immune Responses in Cutaneous Leishmaniasis: In vitro Thelper1/Thelper2 Cytokine Profiles Using Live Versus Killed Leishmania major
por: Miramin-Mohammadi, Akram, et al.
Publicado: (2021)

Comparison of cytokine profile of IFN-γ, IL-5 and IL-10 in cutaneous leishmaniasis using PBMC vs. whole blood
por: Mohammadi, Akram Miramin, et al.
Publicado: (2019)

Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis
por: Eskandari, Seyed Ebrahim, et al.
Publicado: (2018)

Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica: study protocol for a randomized, controlled trial
por: Eskandari, Seyed Ebrahim, et al.
Publicado: (2021)

The efficacy of hydro alcoholic extract of Seidlitzia rosmarinus on experimental zoonotic cutaneous leishmaniasis lesions in murine model
por: Ahmadi, Maryam, et al.
Publicado: (2014)

Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (SinaAmpholeish) on Healthy Volunteers: Phase I Clinical Trial
por: ESKANDARI, Seyed Ebrahim, et al.
Publicado: (2019)

Potential biomarkers of immune protection in human leishmaniasis
por: Rostami, Mahmoud Nateghi, et al.
Publicado: (2021)

CD8(+) T Cells as a Source of IFN-γ Production in Human Cutaneous Leishmaniasis
por: Nateghi Rostami, Mahmoud, et al.
Publicado: (2010)

Treatment of Cutaneous Lesion of 20 Years’ Duration Caused by Leishmanization
por: Khamesipour, Ali, et al.
Publicado: (2012)

Efficacy of intra-lesional injections of meglumine antimoniate once a week vs. twice a week in the treatment of cutaneous leishmaniasis caused by L. tropica in Iran: A randomized controlled clinical trial
por: Javadi, Amir, et al.
Publicado: (2022)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Cutaneous Leishmaniasis in Suspected Patients Referred To the Center for Research and Training in Skin Diseases and Leprosy, Tehran, Iran from 2008 To 2011
por: MOHAMMADI, Akram MIR AMIN, et al.
Publicado: (2013)

IL-23 and IL-27 Levels in Macrophages Collected from Peripheral Blood of Patients with Healing Vs Non-Healing Form of Cutaneous Leishmaniasis
por: Tolouei, S, et al.
Publicado: (2012)

Hoarseness as the Presenting Symptom of Visceral Leishmaniasis with Muco-Cutaneous Lesions: A Case Report
por: MORTAZAVI, Hossein, et al.
Publicado: (2015)

Bacterial Contamination in Cutaneous Leishmaniasis: Its Effect on the Lesions’ Healing Course
por: Layegh, Pouran, et al.
Publicado: (2015)

Effect of secondary infection on epithelialisation and total healing of cutaneous leishmaniasis lesions
por: Antonio, Liliane de Fátima, et al.
Publicado: (2017)

Immunization Against Cutaneous Leishmaniasis by Alginate Microspheres Loaded With Autoclaved Leishmania Major (ALM) and Quillaja Saponins
por: Tafaghodi, Mohsen, et al.
Publicado: (2016)

Efficacy of Microwave and Infrared Radiation in the Treatment of the Skin Lesions Caused by Leishmania major in an Animal Model
por: Eskandari, SE, et al.
Publicado: (2012)

Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania major
por: Hoseini, Shervin Ghaffari, et al.
Publicado: (2014)

The Comparison of the IFN-ɤ, TNF-α and IL-10 Cytokines in Healing and Non-healing Cutaneous Leishmaniasis
por: Taraghian, Mina, et al.
Publicado: (2021)

Efficacy of fibroblast transplantation in the healing of cutaneous leishmaniasis scar: A case report
por: Faghihi, Faezeh, et al.
Publicado: (2023)

Performance of a universal PCR assay to identify different Leishmania species causative of Old World cutaneous leishmaniasis
por: Nateghi Rostami, Mahmoud, et al.
Publicado: (2020)

Identification of Leishmania Isolates From Healing and Nonhealing Cutaneous Leishmaniasis Patients Using Internal Transcribed Spacer Region PCR
por: Tolouei, Sepideh, et al.
Publicado: (2014)

Healed Lesions of Human Cutaneous Leishmaniasis Caused By Leishmania major Do Not Shelter Persistent Residual Parasites
por: Sghaier, Rabiaa M., et al.
Publicado: (2022)

Comparison the efficacy of ablative CO(2) laser and fractional CO(2) laser on the healing of cutaneous leishmaniasis scars
por: Nilforoushzadeh, Mohammad Ali, et al.
Publicado: (2014)

Comparative evaluation of salivary glands proteomes from wild Phlebotomus papatasi –proven vector of zoonotic cutaneous leishmaniasis in Iran
por: Maryam Ghafari, Seyedeh, et al.
Publicado: (2020)

Lived Experiences of Patients Suffering from Acute Old World Cutaneous Leishmaniasis: A Qualitative Content Analysis Study from Iran
por: Khatami, Alireza, et al.
Publicado: (2018)

Rare variants of cutaneous leishmaniasis presenting as eczematous lesions
por: Ayatollahi, Jamshid, et al.
Publicado: (2014)

Topical Bambusa vulgaris Extract Enhances Wound Healing in Cutaneous Leishmaniasis
por: Ghanbarinasab, Zahra, et al.
Publicado: (2021)

Identification of etiologic agents of cutaneous Leishmaniasis in palpebral position followed by effective therapy
por: Saberi, Sedigheh, et al.
Publicado: (2017)

Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to Leishmania major
por: Hoseini, Shervin G., et al.
Publicado: (2012)

Plasma levels of interlukin-4 and Interferon-γ in patients with chronic or healed cutaneous leishmaniasis
por: Taheri, Ahmad Reza, et al.
Publicado: (2014)

Evaluation of a Possible Synergistic Effect of Meglumine Antimoniate with Paromomycin, Miltefosine or Allopurinol on in Vitro Susceptibility of Leishmania tropica Resistant Isolate
por: REZAEI RIABI, Tahereh, et al.
Publicado: (2013)

Signaling pathways in cutaneous wound healing
por: Krizanova, Olga, et al.
Publicado: (2022)

Improvement of the Solubility Amphotericin B Using Olive Oil Nanoemulsion Coated with Chitosan for More Effective Treatment of Zoonotic Cutaneous Leishmaniasis
por: Taghizadeh, Elnaz, et al.
Publicado: (2021)

Taurine improves the wound healing process in cutaneous leishmaniasis in mice model, based on stereological parameters
por: Ashkani-Esfahani, Soheil, et al.
Publicado: (2014)

The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy
por: Lakhal-Naouar, Ines, et al.
Publicado: (2015)

Label-free quantitative proteomic analysis reveals potential biomarkers for early healing in cutaneous leishmaniasis
por: Montoya, Andrés, et al.
Publicado: (2019)

Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major Induced Cutaneous Leishmaniasis
por: Hejazi, SH, et al.
Publicado: (2012)

Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major induced Cutaneous Leishmaniasis
por: Hejazi, SH, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g6f1te33gaeg83e1e24aqi46fs